register

Human Resources

Does artificial intelligence reduce unconscious bias in the hiring process?

Health Industry Hub | March 14, 2022 |

Human Resources: Artificial intelligence (AI) can be an efficient tool for recruiting candidates in workplaces across Australia, but new research has found many recruiters are unsure how to use AI to reduce rather than amplify bias.    

Monash University, Diversity Council Australia and Hudson RPO are undertaking a series of ground-breaking studies exploring the impact of unconscious bias on recruitment and selection decisions that use artificial intelligence.  

The first stage of the study, AI: Neither Friend nor Foe for D&I, asked hiring professionals, AI developers, academics and industry experts to share their insights into the use of AI tools in recruitment and their impact on diverse people.    

DCA CEO Lisa Annese said that preliminary research shows that while AI can make recruitment fairer, hiring professionals and developers alike must have diversity and inclusion skills to ensure AI tools address bias effectively.    

“Artificial intelligence can be an efficient, convenient, and supportive tool for recruiting professionals in workplaces across Australia,” Ms Annese said.    

“But for AI to support unbiased recruitment, there needs to be more support for recruiting professionals on how to use these tools to eliminate rather than amplify bias. Developers say AI can remove bias from recruitment to drive workplace diversity and inclusion, but the research heard recruiting professionals were unsure how to customise the tools they use, which left them uncertain about their impact on bias in recruitment.”  

You may also like: Why only 19% of Aussie employees say their workplace is fair? 

Monash University Professor Andreas Leibbrandt said the findings suggest that for AI tools to disrupt biases in recruitment, users need to have at least a basic understanding of its functioning, limitations and strengths.   

“To generate this level of understanding, it is crucial that AI developers and providers, HR leaders and recruiters, and social scientists work together,” Professor Leibbrandt said.   

Kimberley Hubble, Hudson RPO CEO APAC, said “One thing this research points to is the need to be very clear about your talent acquisition strategy, which roles may benefit from an AI-based tool and where in the process you would use it.   

“Like any technology, it isn’t about using AI for AI’s sake. Recruitment and HR leaders need to focus on driving outcomes and then working out where AI fits within this framework.”


News & Trends - MedTech & Diagnostics

Government's rejection of COVID Royal Commission a stark contrast to the UK and NZ

Government’s rejection of COVID Royal Commission a stark contrast to the UK and NZ

Health Industry Hub | September 20, 2024 |

The Albanese government has dismissed the Senate legal and constitutional committee’s proposal for a COVID-19 pandemic royal commission with one […]

More


News & Trends - Biotechnology

AusBiotech and MTPConnect Unite for Landmark Summit on Australia’s Biotech and Medtech Future

AusBiotech and MTPConnect unite for landmark Summit on the nation’s biotech and medtech future

Health Industry Hub | September 20, 2024 |

AusBiotech and MTPConnect have announced an ambitious new collaboration to host Australia’s first National Biotech and Medtech Development and Commercialisation […]

More


ESG

Wear It Red Day ignites national movement for chronic pain recognition, demanding voices be heard

Wear It Red Day ignites national movement for chronic pain recognition, demanding voices be heard

Health Industry Hub | September 20, 2024 |

Today marks the first ever national Wear It Red Day. An initiative of Painaustralia, the national peak advocacy body for […]

More


News & Trends - Pharmaceuticals

Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients

Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients: New study

Health Industry Hub | September 20, 2024 |

Pharma News: New research from the led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) […]

More


This content is copyright protected. Please subscribe to gain access.